Filing Details

Accession Number:
0001144204-13-060919
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-13 14:51:02
Reporting Period:
2013-11-12
Filing Date:
2013-11-13
Accepted Time:
2013-11-13 14:51:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346824 Ra Capital Management, Llc C/O Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2013-11-12 1,795,000 $2.48 22,256,007 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
Footnotes
  1. The securities purchased include 1,418,050 shares for RA Capital Healthcare Fund, L.P. (the "Fund") and 376,950 shares for an account owned by Blackwell Partners, LLC (the "Blackwell Account").
  2. Following the transactions set forth on Table I above, 17,248,214 shares are held by the Fund, and 5,007,793 shares are held in the Blackwell Account.
  3. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Blackwell Account. Peter Kolchinsky is the sole manager of the Adviser. In their respective capacities, each of Mr. Kolchinsky and the Adviser may be deemed to beneficially own the reported securities.
  4. Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interests therein. The filing of this Form 4 shall not be construed as an admission that Mr. Kolchinsky or the Adviser is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of securities reported herein.